Skip to content
Recall Observatory FDA recall evidence

Drug product

Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals, Inc. Morgantown, WV 26505, NDC 0378-1352-01

D-0978-2018

July 09, 2018

Class III

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 80454
Status
Terminated
Classification
Class III
Quantity
28,436 bottles
Official record key
drug-enforcement:D-0978-2018

Official wording

Reason: Subpotent Drug

Code information: Lot #: 2007979, Exp. 11/30/2020

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent